WHO ICTRP trial
The Promysed Land: Clinical use of additional cardiac imaging and biomarkers in…
NL-OMON48167 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON48167 |
|---|---|
| Public title | The Promysed Land: Clinical use of additional cardiac imaging and biomarkers in diagnosis and evaluation of cardiac sarcoidosis |
| Scientific title | The Promysed Land: Clinical use of additional cardiac imaging and biomarkers in diagnosis and evaluation of cardiac sarcoidosis - The Promysed Land |
| Primary sponsor | Foundation for Sarcoidosis Research |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | Netherlands;United Kingdom;United States of America |
| Conditions | Cardiac sarcoidosis;10028593;Cardiac sarcoidosis |
| Interventions | ;Cardiac sarcoidosis;Sarcoidosis with heart involvement |
| Registration date | Mar 18, 2020 |
| Target size | 200 |
| Secondary IDs | NL71111.100.19 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: